Takeda Pharmaceutical Dividend
Dividend criteria checks 4/6
Takeda Pharmaceutical is a dividend paying company with a current yield of 4.66%.
Key information
4.7%
Dividend yield
204%
Payout ratio
Industry average yield | 2.4% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | JP¥91.82 |
Dividend yield forecast in 3Y | 4.9% |
Recent dividend updates
Takeda Pharmaceutical (TSE:4502) Is Due To Pay A Dividend Of ¥94.00
Mar 28Takeda Pharmaceutical (TSE:4502) Has Announced A Dividend Of ¥94.00
Mar 13Takeda Pharmaceutical (TSE:4502) Will Pay A Dividend Of ¥94.00
Feb 26Recent updates
Some Investors May Be Willing To Look Past Takeda Pharmaceutical's (TSE:4502) Soft Earnings
May 21Takeda Pharmaceutical Company Limited Just Recorded A 6.0% EPS Beat: Here's What Analysts Are Forecasting Next
May 12Takeda Pharmaceutical (TSE:4502) Is Due To Pay A Dividend Of ¥94.00
Mar 28Takeda Pharmaceutical (TSE:4502) Has Announced A Dividend Of ¥94.00
Mar 13Takeda Pharmaceutical (TSE:4502) Will Pay A Dividend Of ¥94.00
Feb 26Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 4502's dividends per share have been stable in the past 10 years.
Growing Dividend: 4502's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
Takeda Pharmaceutical Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (4502) | 4.7% |
Market Bottom 25% (JP) | 1.7% |
Market Top 25% (JP) | 3.4% |
Industry Average (Pharmaceuticals) | 2.4% |
Analyst forecast in 3 Years (4502) | 4.9% |
Notable Dividend: 4502's dividend (4.66%) is higher than the bottom 25% of dividend payers in the JP market (1.68%).
High Dividend: 4502's dividend (4.66%) is in the top 25% of dividend payers in the JP market (3.38%)
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (204.2%), 4502's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (130.5%), 4502's dividend payments are not well covered by cash flows.